Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

March 11, 2012

Genzyme Corporation v. Invagen Pharmaceuticals, Inc.

Track this case

Case Number:

1:12-cv-01819

Court:

New York Southern

Nature of Suit:

Patent

Judge:

Jed S. Rakoff

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 16, 2012

    Genzyme Targets InvaGen Over Kidney Treatment Generics

    Genzyme Corp. sued InvaGen Pharmaceuticals Inc. on March 12 in New York, in an attempt to prevent the company from making and marketing generic versions of chronic kidney disease medications Renagel and Renvela.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login